CRADA "reasonable pricing" clauses
Executive Summary
Sen. Lieberman (D-Conn.) says he will work on reaching an administrative agreement -- or "if not, I'll be prepared to introduce legislation" -- to eliminate the use of "reasonable pricing" clauses in Cooperative Research & Development Agreements between the National Institutes of Health and industry. Lieberman made his opinion of reasonable pricing known during a May 26 Senate Small Business Committee hearing on childhood disease research. Reps. Waxman (D-Calif.) and Wyden (D-Ore.) are working on CRADA legislation ('The Pink Sheet" April 11, p. 3)